Kempner Capital Management’s Amgen AMGN Stock Holding History

Kempner Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,691	Closed	-$1.33M	–	51
2024 Q1	$1.33M	Hold	4,691	–	–	0.72%	37
2023 Q4	$1.35M	Sell	4,691 -2	-0%	-$545	0.76%	38
2023 Q3	$1.26M	Hold	4,693	–	–	0.76%	41
2023 Q2	$1.04M	Hold	4,693	–	–	0.67%	42
2023 Q1	$1.14M	Hold	4,693	–	–	0.66%	41
2022 Q4	$1.23M	Sell	4,693 -4,646	-50%	-$1.25M	0.75%	44
2022 Q3	$2.1M	Hold	9,339	–	–	1.39%	31
2022 Q2	$2.27M	Hold	9,339	–	–	1.38%	33
2022 Q1	$2.26M	Buy	9,339 +17	+0.2%	+$3.91K	1.24%	35
2021 Q4	$2.1M	Buy	+9,322	New	+$1.97M	1.24%	34

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kempner Capital Management's AMGN Position: Q2 2024 in Review

Kempner Capital Management sold out of Amgen (AMGN) in Q2 2024, closing a stake of 4,691 shares — an estimated $1.33M sold.

Kempner Capital Management first reported a position in AMGN in Q4 2021 and held it in 10 quarters. The position peaked at $2.27M in Q2 2022. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

Kempner Capital Management reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
Kempner Capital Management sold 4,691 Amgen shares in Q2 2024, an estimated $1.33M.
Kempner Capital Management first reported a position in Amgen in Q4 2021 and held it in 10 quarters.
Kempner Capital Management's Amgen position peaked at $2.27M in Q2 2022.
2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Kempner Capital Management's 13F filing for Q2 2024, filed 19 Jul 2024.